Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Completed

Phase 3 Results N/A

Summary of Purpose

The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 November 2011.

1 Aug 2001 10 Dec 2004 1 Nov 2005 1 Nov 2005 1 Nov 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available